Berlin Heart

Executive Summary

Berlin Heart is a private medical device company specializing in ventricular assist devices (VADs) for severe heart failure, with a unique focus on pediatric patients. Its EXCOR® Pediatric system is the only FDA-approved VAD for children, serving as a critical bridge to cardiac transplantation. The company also markets the EXCOR® Adult system in international markets. Founded in 1997 and headquartered in The Woodlands, Texas, Berlin Heart operates in a niche but vital segment of cardiovascular care. Despite competition from larger players like Abbott and Medtronic in adult VADs, the company's pediatric monopoly and established clinical presence provide a strong foundation. However, as a private entity with limited public disclosures, growth visibility is moderate. Key opportunities lie in expanding adult VAD adoption in the U.S. and entering new geographic markets, though regulatory and commercial timelines remain uncertain.

Upcoming Catalysts (preview)

• Q4 2026FDA Approval of EXCOR® Adult System in the U.S.60% success
• Q2 2026Expansion into Asian Markets (e.g., Japan, China)70% success
• TBDNext-Generation Pediatric VAD Development Milestone50% success